Skip to content

When to start PSA testing, how often to repeat it and when to stop

When to start, how often to repeat the test and when it is reasonable to stop.

Dr. Petronio Melo, urologistA reference in prostate cancer
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 17, 2026
Book a consultation
Drawing of the prostate seen from above next to a calendar page with one day circled, like the test that comes back every year
On this page

Quick answer

The European guideline advises starting PSA testing at 50, at 45 with a family history or African ancestry, and at 40 for carriers of a BRCA2 mutation.1 The Brazilian Society of Urology advises 50, or 45 for Black men and for men with a first-degree relative who had the disease.2 In my practice, I recommend starting at 40 for all men, repeating the test once a year while it stays normal, and continuing for as long as a man is healthy and has a life expectancy above 10 years.

What each organization recommends

The organizations do not agree on everything, but all of them ask for a conversation about risks and benefits before the test.

OrganizationWhen to startIntervalUntil when
European guideline50; 45 with a family history or African ancestry; 40 with a BRCA2 mutation12 years if the PSA is above 1 ng/mL at 40 or above 2 ng/mL at 60; up to 8 years for others1With a life expectancy under 15 years, benefit is unlikely1
American guideline45 to 50; 40 to 45 for Black men, men with a germline mutation or a strong family history4Every 2 to 4 years from 50 to 694Individual decision based on age, PSA, risk, life expectancy and general health4
Brazilian Society of Urology (SBU)50; 45 for Black men or men with a first-degree relative with the disease2Not definedAfter 75, only with a life expectancy above 10 years2
Brazilian Ministry of Health and INCANo population-wide screening; shared decision with men who ask for the test3Not definedNot defined
My practice40, for all men1 year, while the PSA is normalWhile a man is healthy and has a life expectancy above 10 years

How these positions differ and what the large trials found is covered in screening and the prostate exam.

Why I recommend starting at 40

Guidelines matter a great deal, and the European one is the one I respect most. In practice, though, I recommend starting PSA testing at 40 for all men. The reason comes from my own patients: I have seen many men aged 40 to 45 with high-risk prostate cancer.

The trials that showed fewer deaths from screening did not start that early. In the European trial, the core group was 55 to 69 years old, and after 23 years there were 13% fewer prostate cancer deaths among the men invited to screening.11 The data on men in their 40s come from a different kind of study, which stored blood from younger men and followed them for decades.

In Sweden, 21,277 men gave blood at a time when PSA testing was almost unheard of. Among men aged 45 to 49, the 10% with the highest PSA, 1.6 ng/mL or more, accounted for 44% of the prostate cancer deaths that followed.5 In a study of American physicians aged 40 to 59, 82% of the fatal cases occurred in men who, between 40 and 49, had a PSA above the median of 0.68 ng/mL.6 The European guideline also recognizes that a baseline PSA can predict prostate cancer mortality over 12 to 20 years.1

What is typical for each age group is in PSA by age, and cancer in younger men is in prostate cancer under 50.

Who is at higher risk

The European and American guidelines single out three higher-risk groups. In my practice, these men already start at 40, like everyone else.

For men with prostate cancer in the family, the European guideline and the Brazilian Society of Urology advise starting at 45.1,2 In a Swedish study of 51,897 brothers of men with prostate cancer, the chance of high-risk cancer by age 75 was 5.2% in the general population, 8.9% with one affected brother and 13.6% with two.7

In the United States, Black men have 67% more cases than White men and twice the death rate from the disease.8 The European guideline and the Brazilian Society of Urology advise starting at 45, and the American guideline between 40 and 45.1,2,4

In the IMPACT study, men aged 40 to 69 with a BRCA2 mutation had PSA tests for 3 years. Compared with men without the mutation, they had more cancer, were diagnosed younger (61 and 64 years) and had more significant tumors: 77% and 40%.9 In another British study, the chance of prostate cancer in these men reached 27% by age 75.10 That is why the European guideline starts at 40 in this group.1

Other genes, and what does not raise the risk, are covered in prostate cancer causes and risk factors.

How often to repeat the test

The European guideline adjusts the interval to the first result. Men with a PSA above 1 ng/mL at 40 or above 2 ng/mL at 60 repeat it every 2 years. For the others, the next test can wait up to 8 years.1 The American guideline advises testing every 2 to 4 years between 50 and 69, and allows the interval to be tailored to each man.4

The Swedish study helps explain these long intervals: men whose PSA was below the median between 45 and 49 had a 0.09% risk of metastasis over the next 15 years.5

In my practice, when the PSA is normal, I repeat it once a year. It is a more cautious choice than the guidelines make, for the same reason as the starting age.

Before each blood draw, I ask for at least 3 days of rest for the prostate: no ejaculation, no cycling and no rectal exam. What can change the result is in what affects PSA, and the effect of finasteride and dutasteride in PSA and finasteride.

When to stop

The benefit of screening takes a long time to show. In the European trial, the drop in deaths was measured after 23 years of follow-up, and the absolute difference was 0.22 percentage points.11 For a man with little time ahead, what remains are the harms of testing, such as biopsies and treatments that may make no difference.1

That is why the guidelines look at life expectancy as well as age. In its text, the European guideline says men with a life expectancy under 10 to 15 years should not have a PSA test without symptoms, and its recommendations consider benefit unlikely under 15 years.1 The Brazilian Society of Urology recommends testing after 75 only for men with a life expectancy above 10 years.2 The American guideline decides case by case, based on age, PSA, risk, life expectancy and general health.4

In my practice, I keep testing while a man is healthy and has a life expectancy above 10 years. An active, healthy 76-year-old may continue, while a younger man with serious illness may not need to.

If the PSA comes back abnormal

The European guideline advises repeating the PSA when it is between 3 and 10 ng/mL, before any other test.1 The American guideline also advises repeating a newly elevated PSA before an MRI or a biopsy.4 To decide on a biopsy, the European guideline recommends a prostate MRI.1

In my practice, when the PSA comes back abnormal, I go straight to a prostate MRI without repeating the test first. I also do not use free PSA routinely, or PSA density before the MRI, because in my view the MRI has made those tests unnecessary. I always look at the density after the MRI, calculated from the prostate volume: with PI-RADS 1 or 2, it is one of the parameters I use, but not the only one, and I weigh everything about the patient before deciding on a biopsy. I explain both in free PSA and PSA density.

With PI-RADS 3 or higher, I always recommend a biopsy. It is transperineal and always done under sedation. Other reasons the PSA can rise are covered in PSA: when to investigate.

How I approach it

  1. At 40I recommend a first PSA for all men. I ask about family history, medications such as finasteride and dutasteride, and any recent urinary infection.
  2. PreparationAt least 3 days with no ejaculation, no cycling and no rectal exam before the blood draw.
  3. Normal PSAI repeat the test once a year.
  4. Abnormal PSAI go straight to a prostate MRI. With PI-RADS 3 or higher, I recommend a biopsy.
  5. Until whenWhile a man is healthy and has a life expectancy above 10 years.

The consultation can be at my office in Vila Mariana or online, in English, with your previous results sent in advance. If you have had PSA tests for years, the sequence of results helps me understand your risk.

When to see a urologist

  • If you are 40 or older and have never had a PSA test
  • If your father, a brother or other relatives had prostate cancer
  • If someone in your family carries a BRCA2 mutation or another risk gene
  • If your PSA came back abnormal or rose from one test to the next
  • At any age, if you have urinary symptoms or blood in your urine

Frequently asked questions

At what age should I start PSA testing?

The European guideline advises starting at 50, at 45 with a family history or African ancestry, and at 40 for carriers of a BRCA2 mutation.1 The American guideline suggests 45 to 50, and 40 to 45 for men at higher risk.4 In my practice, I recommend starting at 40 for all men. Men with a BRCA2 mutation or many cases in the family also start at 40 with me, with a PSA once a year.

Why start at 40 when the guidelines say 45 or 50?

Because I have seen many men aged 40 to 45 with high-risk prostate cancer. Studies also show that a PSA measured at that stage of life helps predict risk over the following decades.5,6 Guidelines matter a great deal, and the European one is the one I respect most. On the starting age, my practice is more cautious.

My father or brother had prostate cancer. Should I start earlier?

Yes. The European guideline and the Brazilian Society of Urology advise starting at 45.1,2 In a Swedish study, the chance of high-risk cancer by age 75 was 8.9% with one affected brother and 13.6% with two, compared with 5.2% in the general population.7 In my practice, all men start at 40.

Do Black men need to start earlier?

Yes. In the United States, Black men have 67% more cases and twice the death rate from the disease.8 The European guideline and the Brazilian Society of Urology advise starting at 45, and the American guideline between 40 and 45.1,2,4

How often should I repeat the PSA test?

The European guideline adjusts the interval to the first result, from 2 up to 8 years.1 The American guideline advises testing every 2 to 4 years between ages 50 and 69.4 In my practice, when the PSA is normal, I repeat it once a year.

At what age can I stop PSA testing?

There is no fixed age. The European guideline considers that men with a life expectancy under 15 years are unlikely to benefit, and the Brazilian Society of Urology, after 75, recommends testing only with a life expectancy above 10 years.1,2 In my practice, I keep testing while a man is healthy and has a life expectancy above 10 years.

Abnormal PSA: should I repeat it or have an MRI?

The European and American guidelines advise repeating the PSA before other tests.1,4 In my practice, when the PSA comes back abnormal, I go straight to a prostate MRI. With PI-RADS 3 or higher, I always recommend a biopsy.

Do I need to prepare for a PSA test?

In my practice, yes. I ask for at least 3 days of rest for the prostate before the test, with no ejaculation, no cycling and no rectal exam.

Who can advise me on PSA testing in São Paulo?

I advise men on PSA testing and prostate cancer screening in São Paulo. I am Dr. Petronio Melo, a urologist and robotic surgeon, CRM-SP 157.598 and RQE 70.275. I hold a PhD from the University of São Paulo Medical School, with award-winning research on artificial intelligence in prostate cancer diagnosis, and I have performed more than 1,500 robotic and laparoscopic surgeries, more than 500 of them robotic. I recommend starting PSA testing at 40 and repeating it once a year, and when the result is abnormal, I go straight to a prostate MRI. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. European Association of Urology; 2026. EAU
  2. Sociedade Brasileira de Urologia. Aconselhamento para o diagnóstico precoce do câncer de próstata. 2020. SBU
  3. Instituto Nacional de Câncer. Ministério da Saúde recomenda o não rastreamento populacional do câncer de próstata. 2023. INCA
  4. Wei JT, Barocas D, Carlsson S, et al. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. J Urol. 2023;210(1):46-53. PubMed
  5. Vickers AJ, Ulmert D, Sjoberg DD, et al. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study. BMJ. 2013;346:f2023. PubMed
  6. Preston MA, Batista JL, Wilson KM, et al. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol. 2016;34(23):2705-2711. PubMed
  7. Bratt O, Drevin L, Akre O, Garmo H, Stattin P. Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study. J Natl Cancer Inst. 2016;108(10):djw110. PubMed
  8. Kratzer TB, Mazzitelli N, Star J, Dahut WL, Jemal A, Siegel RL. Prostate cancer statistics, 2025. CA Cancer J Clin. 2025;75(6):485-497. PubMed
  9. Page EC, Bancroft EK, Brook MN, et al. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers. Eur Urol. 2019;76(6):831-842. PubMed
  10. Nyberg T, Frost D, Barrowdale D, et al. Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study. Eur Urol. 2020;77(1):24-35. PubMed
  11. Roobol MJ, de Vos II, Månsson M, et al. European Study of Prostate Cancer Screening: 23-Year Follow-up. N Engl J Med. 2025;393(17):1669-1680. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation

Related guides